Xenetic Biosciences Inc
Biotechnology
Healthcare
XBIO
1.54 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
3.48
52 week high
4.58
high
5.27
52 week low
2.30
low
2.90
growth
-2.76 %
previous Close
3.15
P/E ratio
market cap
6.23 M
div yield
0
usd
Sep 2024
qoq
revenue
614 K
-15.44 %
net incoming
-436.67 K
65.72 %
eps
0.00 %
66.27 %
eps surprise
-100.00 %
net profit margin
-71.09 %
104.00 %
operating incoming
-499.47 K
62.65 %
net change in cash
-459.04 K
12.58 %
cash on hand
6.84 M
-6.29 %
cost of revenue
0.00 %
top top